Korro Bio, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue01.3M1.1M1.5M2.5M2.3M00
Cost of Goods Sold380K649K000000
Gross Profit-380K643K1.1M1.5M2.5M2.3M00
R&D Expenses13.0M11.0M13.8M21.0M19.7M17.0M16.0M17.1M
Operating Expenses20.1M16.5M20.3M28.7M27.6M25.3M23.3M24.1M
Operating Income-20.4M-15.9M-19.2M-27.2M-25.0M-23.0M-23.3M-24.1M
Other Income / Gains906K-33.5M1.2M1.4M1.6M1.9M2.3M2.3M
Net Income-19.6M-50.0M-18.1M-25.8M-23.4M-21.2M-21.0M-21.8M
EPS (Diluted)-1.69-5.33-1.92-2.74-2.49-2.26-2.26-2.43
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00.4981.001.001.001.0000
General And Administrative Expenses7.5M6.2M6.5M6.9M7.8M8.3M6.4M6.1M
Selling And Marketing Expenses0003.4M003.8M3.7M
Selling General And Administrative Expenses7.5M6.2M6.5M10.3M7.8M8.3M10.2M9.8M
Other Expenses-380K-649K0-2.7M00-2.9M-2.9M
Cost And Expenses20.4M17.2M20.3M28.7M27.6M25.3M23.3M24.1M
Interest Income00000000
Interest Expense00000000
Depreciation And Amortization380K649K1.2M1.2M1.2M1.3M865K721K
Ebitda-20.1M-15.2M-16.9M-26.0M-23.8M-21.8M-22.4M-23.4M
Ebitdaratio0-11.791-15.488-17.791-9.331-9.59400
Operating Income Ratio0-12.293-17.649-18.632-9.812-10.14500
Income Before Tax-19.5M-49.4M-18.1M-25.8M-23.4M-21.1M-21.0M-21.8M
Income Before Tax Ratio0-38.24-16.57-17.65-9.171-9.28900
Income Tax Expense95K636K01K0103K-9K30K
Net Income Ratio0-38.732-16.57-17.651-9.171-9.33500
Epsdiluted-1.69-5.33-1.92-2.74-2.49-2.26-2.26-2.43
Weighted Average Shs Out11.6M9.4M9.4M9.4M9.4M8.9M9.3M9.0M
Weighted Average Shs Out Dil11.6M9.4M9.4M9.4M9.4M8.9M9.3M9.0M